1、MIL-C-83302D (3) 68 977770b 0322783 O MI L-C-81 302D AMENDMENT 1 28 September 1987 MILITARY SPECIFICATION CLEANING, COMPOUND, SOLVENT, TRICHLOROTRIFLUOROETHANE This amendment forms a part of MIL-C-81302D, dated 16 April 1985, and is approved for use by all Departments and Agencies of the Department
2、of Defense. PAGE 8 5.1 After “level A or“ delete “C“ and substitute “commercial.“ PAGE 9 a. 5.1.2 Delete and substitute: “5.1.2 Commercial. The solvent shall be preserved in accordance with ASTM D 3951. II b. 5.2 After B or“ delete “C“ and substitute “commercial.“ c. 5.2.3 Delete and substitute: “5.
3、2.3 Commercial. The solvent shall be packed in accordance with ASTM D 3951. I PAGE 10 5.3.2 Delete and substi tute: “5.3.2 Warning labels. Type-I and II containers shall be marked with warning labels which read as follows: TRICHLOROTRIFLUOROETHANE WARNING BREATHING VAPOR CAN BE FATAL Vapor concentra
4、tion immediately dangerous to life is almost odorless, colorless and tasteless. May cause impairment of manual dexterity and vigilance. Breathing high concentrations may cause death or serious physical harm. AMSC N/A FSC 6850 DISTRIBUTION STATEMENT A: Approved for public release; dlstribution is unl
5、imited. Page 1 of 4 Provided by IHSNot for ResaleNo reproduction or networking permitted without license from IHS-,-,-MIL-C-81302D PAGE 10 (Continued) . In case of spi1 1 warn others and escape immediately. , May dilute or displace oxygen below levels necessary to sustain life, Low areas are especia
6、lly susceptible to oxygen displacement. . Avoid breathing vapor. Liquid is irritant. Avoid skin and eye contact. Use the smallest amount possible to perform required task. Assure good ventilation to maintain vapor levels below maximum permissible concentrations. . When used indoors where dangerous v
7、apor concentrations are possible (when one cup is used in a space of 25 cubic meters (883 cubic feet): 1. Use halocarbon monitor with alarm; 2. Have emergency breathing device immediately available to everyone unless immediate escape to vapor-free area is possible. . Do not enter storage areas until
8、 they have been ventilated. . Do not use in the general vicinity of welding, open flame or hot surfaces. Heat and ultraviolet radiation may cause the formation of highly toxic by-products. FIRST AID: In case of direct contact, remove contaminated clothing and wash involved skin with soap and water.
9、Seek medical attention if irritation occurs. In case of eye contact, flush with potable water for at least 15 minutes. Call a physician. NOTE: Contact lenses should not be worn when using the chemical. If inhaled, remove,to fresh air. If not breathing, give artificial respiration, preferably mouth-t
10、o-mouth, If breathing is difficult give oxygen. Call a physician. Do not give epinephrine or similar drugs. If ingested do not induce vomi ti ng. Note to Physicians: Trichlorotrifluoroethane has caused cardiac sensitization to epinephrine in experimental animals (dogs). Cardiac arrhythmia, including
11、 ventricular fibrilla- tion could occur if epinephrine or one of its congeners is administered to patients exposed to high concentrations of trichlorotrifluoroethane. Medical use of epinephrine or any of its congeners is contraindicated except for patients with no arterial perfusion. 2 Provided by I
12、HSNot for ResaleNo reproduction or networking permitted without license from IHS-,-,-MI L-C-81 302D SPILLS: Absorb large spills with commercial absorbant. Collect in covered metal drums for disposal in accordance with federal, state and local regulations. NIOSHIMSHA approved respiratory protection b
13、ased on maximum potential exposure of conc=ern must be used.“ PAGE 11 5.3.3 Delete and substitute: “5.3.3 Warning labels. Type IIA pressurized containers (12 and 16 ounce containers) shall be marked with warning labels which read as follows: TRICHLOROTRIFLUOROETHANE WARN1 NG BREATHING VAPOR CAN BE F
14、ATAL . Vapor concentration.immediately dangerous to life is almost odorless, colorless and tasteless. May cause impairment of manual dexterity and vigilance. Breathing high concentrations may cause death or serious physical harm. . In case of spi 11 warn others and escape immediately. . May dilute o
15、r displace oxygen below-levels necessary to sustain life. Low areas are especially susceptible to oxygen displacement. . Avoid breathing vapor. Liquid is irritant. Avoid skin and eye contact. Use the smallest amount possible to perform required task. Assure good ventilation to maintain vapor levels
16、below maximum permissible concentrations. . When used indoors where dangerous vapor concentrations are possible (when one cup is used in a space of 25 cubic meters (883 cubic feet): 1. Use halocarbon monitor with alarm; 2. Have emergency breathing device immediately available to everyone unless imme
17、diate escape to vapor-free area is possible. . Do not enter storage areas until they have been ventilated. . Do not use in the general vicinity of welding, open flame or hot . surfaces. Heat and ultraviolet radiation may cause the formation of highly toxic by-products. . Contents under pressure. Kee
18、p away from direct sunlight, radiators; hot water or other sources of heat. . Do not store above O“C (122F). . Do not puncture can or incinerate. 3 Provided by IHSNot for ResaleNo reproduction or networking permitted without license from IHS-,-,-MI L-C-81 302D PAGE 11 (Continued) FIRST AID: In case
19、of direct contact, remove contaminated clothing and wash involved skin with soap and water. Seek medi cal attention if irritation occurs. In case of eye contact, flush with potable water for at least 15 minutes. Call a physician. NOTE: Contact lenses should not be worn when using the chemical. If in
20、haled, remove to fresh air. If not breathing, give artificial respiration, preferably mouth-to-mouth. If breathing is difficult, give oxygen. Call a physician. Do not give epinephrine or similar drugs. If ingested do not induce vomi ti ng. Note to Physicians: Trichlorotrifluoroethane has caused card
21、iac sensitization to epinephrine i.n experimental animals (dogs). Cardiac arrhythmia, including ventricular fibrilla- tion could occur if epinephrine or one of its congeners is administered to patients exposed to high concentrations of trichlorotrifluoroethane. Medical use of epinephrine or any of i
22、ts congeners is contraindicated except for patients with no arterial perfusion.“ Custodians: Army - MI Navy - AS Air Force 2 68 Review activities: Army - SM Navy - OS, SH DLA - GS MISC - DS Preparing activity: Navy - AS (Project No. 6850-0839) User activities: Army - ER MISC - NA 4 Provided by IHSNot for ResaleNo reproduction or networking permitted without license from IHS-,-,-
